Position in LGND
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$385,629
+$146,050 QoQ
Shares Held
1,220
+1.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#261
of 413 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Argent Trust Co holds $4,756,008 across 11 Biotechnology names. LGND ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,749 | $1,090,571 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,014 | $1,000,412 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
1,426 | $530,001 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
This page
|
1,220 | $385,629 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
5,598 | $307,553 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,174 | $287,359 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
3,018 | $239,296 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
2,679 | $232,938 |
All Filings in LGND
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $385,629 | 1,220 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $239,579 | 1,200 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||